| Mr Robert Larry Smith, FNP-BC | |
|
260d Shoppingway Blvd, West Memphis, AR 72301-7230 | |
| (901) 303-5040 | |
| Not Available |
| Full Name | Mr Robert Larry Smith |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 260d Shoppingway Blvd, West Memphis, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134450307 | NPI | - | NPPES |
| PENDING | Medicaid | TN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michael E Steuer Md Pc | 0648229971 | 14 |
News Archive
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.
› Verified 1 days ago
| Entity Name | Michael E Steuer Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861824559 PECOS PAC ID: 0648229971 Enrollment ID: O20090413000357 |
News Archive
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.
› Verified 1 days ago
| Entity Name | Cordova Pain Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437565900 PECOS PAC ID: 1759500523 Enrollment ID: O20140910001813 |
News Archive
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Larry Smith, FNP-BC 5504 North St, Bartlett, TN 38134-3458 Ph: (901) 382-0347 | Mr Robert Larry Smith, FNP-BC 260d Shoppingway Blvd, West Memphis, AR 72301-7230 Ph: (901) 303-5040 |
News Archive
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study. The recently completed study showed that a new monoclonal antibody (RAB-1) resulted in protective antibody levels in the serum of treated subjects equal to the current standard of treatment, which is often not available in the areas of the world hit hardest by rabies.
To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.
› Verified 1 days ago
Angela Christine Jones, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 West Broadway, West Memphis, AR 72301 Phone: 870-394-7010 Fax: 870-394-7001 | |
Nykkia N Sellers, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 N Missouri St Ste 2, West Memphis, AR 72301 Phone: 870-551-4409 | |
Marlo S. Williams, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1028 N Missouri St Ste 6, West Memphis, AR 72301 Phone: 870-400-0263 Fax: 870-400-0293 | |
Nikita Coleman-smith, AGPCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 N 7th St, West Memphis, AR 72301 Phone: 870-735-3842 | |
Celena Lanette Jones, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 N 7th St, West Memphis, AR 72301 Phone: 870-735-3842 Fax: 870-394-4872 | |
Ms. Kathleen M Maples, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 W Tyler Ave, West Memphis, AR 72301 Phone: 501-658-2718 Fax: 501-724-3305 |